An interim analysis has shown that patients with ALK-positive advanced non-small cell lung cancer (NSCLC) who received brigatinib lived longer progression-free compared with patients who received crizotinib in a multicenter, randomized phase 3 ALTA-1L trial.  These  updated trial results were recently published in the Journal of Clinical Oncology.

Results of an exploratory, retrospective analysis that evaluated comprehensive genomic profiling (CGP) assay results performed on cell-free, circulating tumor DNA (ctDNA) and tumor tissue obtained from “real-world” patients with advanced non-small cell lung cancer (NSCLC) supported the routine clinical use of ctDNA-based CPG to facilitate selection of targeted therapy in this setting, according to findings published in Lung Cancer.

In this article in the IASLC online news, Dr Arya Amini and Dr Chad G. Rusthoven discuss the options available and whether a new gold standard should be definated for managing brain metastases in NSCLC.  We'll be discussing brain metastses management in one of our forthcoming webinars - watch this space for details

Don't miss the first in our series of webinars running for the remainder of 2020. Mesothelioma in the shadow of COVID-19, provides an update for all CNS who manage people with mesothelioma. The webinar will feature an update on current trials and treatments by Anne Moylan and Liz Darlison will be sharing the results of several surveys which highlight the impact and effects of COVID-19 on workforce and patients. Register now.

Brought to you by the Christie School of Oncology this one-day virtual workshop will cover  lung screening and early detection - emerging technologies, lung cancer pre-habilitation, exploring the treatment modalities for NSCLC and the social aspect of living with lung cancer and the psychological impact of remission.  More details.  Price from £32

Our Good Practice Guide is available online in a fully searchable format and provides great tips to help you in every day practice. We'd like to keep this guide up to date with current examples of good practice including any learning from COVID-19. If you have an example of good practice please do share it online using our simple webform.

If you haven't yet followed us on Twitter please take a look and sign up @LCN_UK. We share relevant information, news and advice for members and those interested in lung cancer management. We are close to 1,000 followers so we've set a target to reach this by the end of the year. Please follow us now and tag us into your news and we'll ensure we share to help us reach our target.

World Lung Day takes place this year on 25 September 2020 and offers an opportunity to shine a spotlight on lung health. Help support this campaign by downloading the pledges and sharing on social media. Find out more.

The Royal College of Nursing has today warned the government that it is “time to pay nursing staff fairly” as it seeks to secure a 12.5% wage increase for its members.  The college has launched its Fair Pay for Nursing campaign, which is calling for a new one-year pay deal, to be implemented as soon as possible.  Help share the campaign message by Tweeting your support using the hashtag #FairPayForNursing